Table 1. Distribution in functional categories of genes regulated by PEDF in A375 human melanoma cell line.
ANGIOGENESIS/ADHESION/MIGRATION/INVASION | |||
---|---|---|---|
Gene symbol | Description | PEDF/Control | |
Hybr. 1 | Hybr. 2 | ||
FN1 | Fibronectin 1 | 14.22 | 16.52 |
VEGFC | vascular endothelial growth factor C | 3.13 | 4.64 |
FLT1 | Fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.05 | 0.07 |
IL8 | Interleukin 8 | 0.36 | 0.36 |
ITGB3 | Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.30 | 0.26 |
ITGB8 | Integrin, beta 8 | 0.11 | 0.19 |
NRP2 | Neuropilin 2 | 0.40 | 0.41 |
PCDH10 | Protocadherin 10 | 0.10 | 0.12 |
PCDH17 | Protocadherin 17 | 0.34 | 0.27 |
PCDHA9 | Protocadherin alpha 9 | 0.46 | 0.48 |
PCDHB7 | Protocadherin beta 7 | 0.34 | 0.34 |
PELO | Integrin, alpha 1 | 0.12 | 0.15 |
TGFA | Transforming growth factor, alpha | 0.03 | 0.04 |
TGFBI | Transforming growth factor, beta-induced, 68kDa | 0.41 | 0.43 |
PROTEASES | |||
---|---|---|---|
Gene symbol | Description | PEDF/Control | |
Hybr. 1 | Hybr. 2 | ||
ADAMTS6 | A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 6 | 3.39 | 8.66 |
ADAM10 | A disintegrin and metalloproteinase domain 10 | 0.46 | 0.46 |
ADAM12 | A disintegrin and metalloproteinase domain 12 (meltrin alpha) | 0.27 | 0.47 |
ADAM19 | A disintegrin and metalloproteinase domain 19 (meltrin beta) | 0.06 | 0.09 |
ADAM23 | A disintegrin and metalloproteinase domain 23 | 0.08 | 0.10 |
CTSH | Cathepsin H | 0.17 | 0.30 |
CTSK | Cathepsin K (pycnodysostosis) | 0.08 | 0.10 |
PLAT | Plasminogen activator, tissue | 0.39 | 0.40 |
PRSS11 | protease, serine, 11 (IGF binding) | 0.07 | 0.04 |
SERPINA3 | Serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 0.05 | 0.04 |
SERPIND1 | Serine (or cysteine) proteinase inhibitor, clade D (heparin cofactor), member 1 | 0.07 | 0.07 |
TIMP1 | Tissue inhibitor of metalloproteinase 1 (erythroid potentiating activity, collagenase inhibitor) | 0.33 | 0.32 |
MELANIN SECRETION | |||
---|---|---|---|
Gene symbol | Description | PEDF/Control | |
Hybr. 1 | Hybr. 2 | ||
MLPH | Melanophilin | 15.70 | 28.90 |
RAB27A | RAB27A, member RAS oncogene family | 0.31 | 0.22 |
MELANOMA PROGRESSION | |||
---|---|---|---|
Gene symbol | Description | PEDF/Control | |
Hybr. 1 | Hybr. 2 | ||
DKK1 | Dickkopf homolog 1 (Xenopus laevis) | 2.86 | 2.87 |
DKK3 | Dickkopf homolog 3 (Xenopus laevis) | 2.28 | 2.85 |
FZD2 | Frizzled homolog 2 (Drosophila) | 2.60 | 2.38 |
FGF13 | Fibroblast growth factor 13 | 0.14 | 0.08 |
FZD1 | Frizzled homolog 1 (Drosophila) | 0.37 | 0.42 |
GAGE1 | G antigen 1 | 0.35 | 0.46 |
GAGE2 | G antigen 2 | 0.11 | 0.10 |
GAGE4 | G antigen 4 | 0.45 | 0.38 |
GAGE5 | G antigen 5 | 0.24 | 0.31 |
IGFBP3 | Insulin-like growth factor binding protein 3 | 0.11 | 0.22 |
INHBA | Inhibin, beta A (activin A, activin AB alpha polypeptide) | 0.18 | 0.24 |
JAG1 | Jagged 1 (Alagille syndrome) | 0.14 | 0.13 |
LEF1 | Lymphoid enhancer-binding factor 1 | 0.48 | 0.37 |
LGALS3 | Lectin, galactoside-binding, soluble, 3 (galectin 3) /// galectin-3 internal gene | 0.23 | 0.21 |
NOTCH2NL | Notch homolog 2 (Drosophila) N-terminal like | 0.29 | 0.26 |
MELANOMA MARKERS | |||
---|---|---|---|
Gene symbol | Description | PEDF/Control | |
Hybr. 1 | Hybr. 2 | ||
MAGEA1 | Melanoma antigen family A, 1 (directs expression of antigen MZ2-E) | 2.78 | 2.78 |
CSPG4 | Chondroitin sulfate proteoglycan 4 (melanoma-associated) | 0.19 | 0.24 |
MIA | Melanoma inhibitory activity | 0.48 | 0.44 |
S100A1 | S100 calcium binding protein A1 | 0.33 | 0.13 |
S100A13 | S100 calcium binding protein A13 | 0.38 | 0.33 |
S100A16 | S100 calcium binding protein A16 | 0.29 | 0.36 |
S100A2 | S100 calcium binding protein A2 | 0.30 | 0.27 |
S100A3 | S100 calcium binding protein A3 | 0.15 | 0.12 |
S100A4 | S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog) | 0.10 | 0.09 |
S100B | S100 calcium binding protein, beta (neural) | 0.13 | 0.10 |
TRANSCRIPTION FACTORS | |||
---|---|---|---|
Gene symbol | Description | PEDF/Control | |
Hybr. 1 | Hybr. 2 | ||
FOXF2 | Forkhead box F2 | 2.16 | 2.32 |
SOX11 | SRY (sex determining region Y)-box 11 | 3.85 | 4.10 |
SOX9 | SRY (sex determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal) | 2.27 | 12.34 |
NFATC2 | Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 | 0.29 | 0.22 |
SOX2 | SRY (sex determining region Y)-box 2 | 0.41 | 0.46 |
SOX5 | SRY (sex determining region Y)-box 5 | 0.20 | 0.08 |
TBX2 | T-box 2 | 0.24 | 0.19 |
APOPTOSIS | |||
---|---|---|---|
Gene symbol | Description | PEDF/Control | |
Hybr. 1 | Hybr. 2 | ||
BID | BH3 interacting domain death agonist | 2.17 | 2.28 |
NGFR | Nerve growth factor receptor (TNFR superfamily, member 16) | 6.67 | 4.56 |
ARHGEF6 | Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 | 0.46 | 0.23 |
BCL2A1 | BCL2-related protein A1 | 0.04 | 0.05 |
BIRC3 | Baculoviral IAP repeat-containing 3 | 0.36 | 0.18 |
FAIM3 | Fas apoptotic inhibitory molecule | 0.32 | 0.30 |
FAS | Fas (TNF receptor superfamily, member 6) | 0.19 | 0.19 |
TNFSF7 | Tumor necrosis factor (ligand) superfamily, member 7 | 0.33 | 0.35 |
CELL PROLIFERATION | |||
---|---|---|---|
Gene symbol | Description | PEDF/Control | |
Hybr. 1 | Hybr. 2 | ||
CCNJ | Cyclin J | 2.04 | 2.91 |
CLEC11A | C-type lectin domain family 11, member A | 3.94 | 3.52 |
CYR61 | Cysteine-rich, angiogenic inducer, 61 | 2.06 | 2.55 |
E2F5 | E2F transcription factor 5, p130-binding | 3.72 | 3.91 |
HDAC9 | Histone deacetylase 9 | 2.51 | 3.35 |
MDK | Midkine (neurite growth-promoting factor 2) | 7.29 | 9.42 |
CCNA1 | Cyclin A1 | 0.10 | 0.08 |
CDKN1A | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.21 | 0.37 |
DUSP4 | Dual specificity phosphatase 4 | 0.39 | 0.32 |
HIPK2 | Homeodomain interacting protein kinase 2 | 0.41 | 0.41 |
IGF1R | Insulin-like growth factor 1 receptor | 0.25 | 0.25 |
IGFBP2 | Insulin-like growth factor binding protein 2, 36kDa | 0.24 | 0.14 |
IGFBP5 | Insulin-like growth factor binding protein 5 | 0.27 | 0.27 |
IGFBP7 | Insulin-like growth factor binding protein 7 | 0.32 | 0.45 |
NDN | Necdin homolog (mouse) | 0.07 | 0.09 |
CYTOKINES | |||
---|---|---|---|
Gene symbol | Description | PEDF/Control | |
Hybr. 1 | Hybr. 2 | ||
IL13RA2 | Interleukin 13 receptor, alpha 2 | 0.41 | 0.44 |
IL1A | Interleukin 1, alpha | 0.16 | 0.11 |
IL1RAP | Interleukin 1 receptor accessory protein | 0.17 | 0.14 |
IL24 | Interleukin 24 | 0.06 | 0.07 |
IL6ST | Interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.38 | 0.38 |
METABOLISM | |||
---|---|---|---|
Gene symbol | Description | PEDF/Control | |
Hybr. 1 | Hybr. 2 | ||
PLTP | phospholipid transfer protein | 2.73 | 2.71 |
ACOX2 | acyl-Coenzyme A oxidase 2, branched chain | 0.49 | 0.30 |
ACSL1 | acyl-CoA synthetase long-chain family member 1 | 0.34 | 0.39 |
ADPGK | ADP-dependent glucokinase | 0.39 | 0.38 |
B3GAT1 | beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) | 0.35 | 0.29 |
CHST11 | carbohydrate (chondroitin 4) sulfotransferase 11 | 0.36 | 0.18 |
IRS2 | insulin receptor substrate 2 | 0.44 | 0.40 |
MGLL | monoglyceride lipase /// monoglyceride lipase | 0.24 | 0.44 |
PLA2G4A | phospholipase A2, group IVA (cytosolic, calcium-dependent) | 0.24 | 0.38 |